The role of the metastasis suppressor gene KAI1 in melanoma angiogenesis

Pigment Cell and Melanoma Research

Volumn 28, Issue 6, 2015, Pages 696-706

  Tang, Yun ^a   Bhandaru, Madhuri ^a   Cheng, Yabin ^a   Lu, Jing ^a,b   Li, Gang ^a   Ong, Christopher J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Akt; Angiogenesis; Inhibitor of growth 4; Interleukin 6; KAI1; Melanoma; VEGF

Indexed keywords

CD31 ANTIGEN; CD82 ANTIGEN; INHIBITOR OF GROWTH 4; INTERLEUKIN 6; MATRIGEL; MESSENGER RNA; PROTEIN; PROTEIN KINASE B; SERINE; UNCLASSIFIED DRUG; VASCULOTROPIN; CELL CYCLE PROTEIN; HOMEODOMAIN PROTEIN; ING4 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IN VIVO STUDY; MELANOMA; MELANOMA ANGIOGENESIS; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION; SKIN TUMOR; TUMOR CELL LINE; VASCULARIZATION;

ANTIGENS, CD82; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; MELANOMA; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84944454561     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12399     Document Type: Article

References (50)

1. American Cancer Society (2012). Cancer Facts & Figures 2012. American Cancer Society (ACS). J. Consum. Health Internet 16, 366-367.
2. Bai, D., Ueno, L., and Vogt, P.K. (2009). Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int. J. Cancer 125, 2863-2870.
3. Balch, C.M., Buzaid, A.C., Soong, S.J. et al. (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19, 3635-3648.
4. Byers, H.R., Etoh, T., Doherty, J.R., Sober, A.J., and Mihm, M.C. Jr (1991). Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am. J. Pathol. 139, 423-435.
5. Campbell, K.J., Rocha, S., and Perkins, N.D. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 13, 853-865.
6. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G., and Levi, B.Z. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736-741.
7. Czubayko, F., Schulte, A.M., Berchem, G.J., and Wellstein, A. (1996). Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl Acad. Sci. USA 93, 14753-14758.
8. Dimmeler, S., and Zeiher, A.M. (2000). Akt takes center stage in angiogenesis signaling. Circ. Res. 86, 4-5.
9. Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikawa, T., Isaacs, J.T., and Barrett, J.C. (1995). KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884-886.
10. Folkman, J. (1974). Proceedings: tumor angiogenesis factor. Cancer Res. 34, 2109-2113.
11. Folkman, J. (2002). Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18.
12. Galbaugh, T., Cerrito, M.G., Jose, C.C., and Cutler, M.L. (2006). EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation. BMC Cell Biol. 7, 34.
13. Guo, C., Liu, Q.G., Zhang, L., Song, T., and Yang, X. (2009). Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 8, 389-396.
14. Hatakeyama, M., Imaizumi, T., Sakaki, H., Yoshida, H., Tanaka, H., Kimura, H., Fukuda, I., and Satoh, K. (2007). Interleukin-1 induces the expression of vascular endothelial growth factor in human pericardial mesothelial cells. Heart Vessels 22, 123-127.
15. Hemler, M.E. (2001). Specific tetraspanin functions. J. Cell Biol. 155, 1103-1107.
16. Houghton, A.N., and Polsky, D. (2002). Focus on melanoma. Cancer Cell 2, 275-278.
17. Ichikawa, T., Ichikawa, Y., and Isaacs, J.T. (1991). Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res. 51, 3788-3792.
18. Ichikawa, T., Ichikawa, Y., Dong, J., Hawkins, A.L., Griffin, C.A., Isaacs, W.B., Oshimura, M., Barrett, J.C., and Isaacs, J.T. (1992). Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res. 52, 3486-3490.
19. Kalluri, R. (2003). Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433.
20. Karar, J., and Maity, A. (2011). PI3K/AKT/mTOR pathway in angiogenesis. Front. Mol. Neurosci. 4, 51.
21. Karst, A.M., Gao, K., Nelson, C.C., and Li, G. (2009). Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int. J. Cancer 124, 494-501.
22. Kim, J.H., Kim, B., Cai, L. et al. (2005). Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 434, 921-926.
23. Li, J., and Li, G. (2010). Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1. Cancer Res. 70, 10445-10453.
24. Liu, F.S., Chen, J.T., Dong, J.T., Hsieh, Y.T., Lin, A.J., Ho, E.S., Hung, M.J., and Lu, C.H. (2001). KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. Am. J. Pathol. 159, 1629-1634.
25. Liu, Y., Mayo, M.W., Nagji, A.S., Smith, P.W., Ramsey, C.S., Li, D., and Jones, D.R. (2012). Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene 31, 1143-1154.
26. Lu, J., Rho, O., Wilker, E., Beltran, L., and Digiovanni, J. (2007). Activation of epidermal akt by diverse mouse skin tumor promoters. Mol. Cancer Res. 5, 1342-1352.
27. Mamou, F., May, K.S., Schipper, M.J., Gill, N., Kariapper, M.S., Nair, B.M., Brewer, G., Normolle, D., and Khan, M.K. (2006). Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitro. Anticancer Res. 26, 1753-1758.
28. Mannion, B.A., Berditchevski, F., Kraeft, S.K., Chen, L.B., and Hemler, M.E. (1996). Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J. Immunol. 157, 2039-2047.
29. Marquez-Rodas, I., Martin Algarra, S., Aviles Izquierdo, J.A., Custodio Cabello, S., and Martin, M. (2011). A new era in the treatment of melanoma: from biology to clinical practice. Clin. Transl. Oncol. 13, 787-792.
30. Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M., and Shiina, M. (2012). IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.) 122, 143-159.
31. Nakamura, K., Mitamura, T., Takahashi, T., Kobayashi, T., and Mekada, E. (2000). Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 275, 18284-18290.
32. Odintsova, E., Van Niel, G., Conjeaud, H., Raposo, G., Iwamoto, R., Mekada, E., and Berditchevski, F. (2013). Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor. J. Biol. Chem. 288, 26323-26334.
33. Ono, M., Handa, K., Withers, D.A., and Hakomori, S. (1999). Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 59, 2335-2339.
34. Qin, L., Bromberg-White, J.L., and Qian, C.N. (2012). Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed. Adv. Cancer Res. 113, 191-239.
35. Shiojima, I., and Walsh, K. (2002). Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90, 1243-1250.
36. Siegel, R., Ma, J., Zou, Z., and Jemal, A. (2014). Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29.
37. Stipp, C.S., Kolesnikova, T.V., and Hemler, M.E. (2003). Functional domains in tetraspanin proteins. Trends Biochem. Sci. 28, 106-112.
38. Tang, J.F., Wen, Q., Sun, J., Zhang, W.M., and Zhu, H.L. (2014a). Advances in the researches on the biological activities and inhibitors of phosphatidylinositol 3-kinase. Anti-Cancer Agents Med. Chem. 14, 673-687.
39. Tang, Y., Cheng, Y., Martinka, M., Ong, C.J., and Li, G. (2014b). Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4. Carcinogenesis 35, 86-95.
40. Tsao, H., and Sober, A.J. (2005). Melanoma treatment update. Dermatol. Clin. 23, 323-333.
41. Tzeng, H.E., Tsai, C.H., Chang, Z.L., Su, C.M., Wang, S.W., Hwang, W.L., and Tang, C.H. (2013). Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma. Biochem. Pharmacol. 85, 531-540.
42. Wang, X., Mccullough, K.D., Franke, T.F., and Holbrook, N.J. (2000). Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275, 14624-14631.
43. Wang, J., Chin, M.Y., and Li, G. (2006). The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation. Cancer Res. 66, 1906-1911.
44. Wani, A.A., Jafarnejad, S.M., Zhou, J., and Li, G. (2011). Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB/interleukin-6 signaling pathway. Oncogene 30, 2778-2788.
45. Wehbe, H., Henson, R., Meng, F., Mize-Berge, J., and Patel, T. (2006). Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res. 66, 10517-10524.
46. Weidner, N. (1995). Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36, 169-180.
47. Weidner, N., Semple, J.P., Welch, W.R., and Folkman, J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
48. Weis, S.M., and Cheresh, D.A. (2011). Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 17, 1359-1370.
49. Wright, M.D., and Tomlinson, M.G. (1994). The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15, 588-594.
50. Zhang, X.A., Bontrager, A.L., and Hemler, M.E. (2001). Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J. Biol. Chem. 276, 25005-25013.